OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glycyrrhizic acid as an adjunctive treatment for depression through anti-inflammation: A randomized placebo-controlled clinical trial
Zhiyong Cao, Yun‐Zi Liu, Jiamei Li, et al.
Journal of Affective Disorders (2020) Vol. 265, pp. 247-254
Closed Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?
Christian Bailly, Gérard Vergoten
Pharmacology & Therapeutics (2020) Vol. 214, pp. 107618-107618
Open Access | Times Cited: 277

Traditional Chinese medicine in COVID-19
Ming Lyu, Guanwei Fan, Guangxu Xiao, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3337-3363
Open Access | Times Cited: 179

Immunomodulatory properties of triterpenes
Gülin Renda, İçim Gökkaya, Didem Şöhretoğlu
Phytochemistry Reviews (2021) Vol. 21, Iss. 2, pp. 537-563
Open Access | Times Cited: 62

Neuroinflammatory Basis of Depression: Learning From Experimental Models
Ruqayya Afridi, Kyoungho Suk
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 57

Association between inflammatory cytokines and symptoms of major depressive disorder in adults
Min Xue, Genwei Wang, Yalian Cui, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22

Application of glycyrrhizic acid and glycyrrhetinic acid in the drug delivery system
Ziwen Zhao, Ming-hui Cai, Ping Wang, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 97, pp. 105754-105754
Closed Access | Times Cited: 8

Glycyrrhizic Acid Mitigates Haloperidol-Induced Neurotoxicity in SHSY-5Y Cells and Rats Via Activation of PI3k/Akt/Nrf2 Pathways
Mohammad Aqeel, Shubham Upadhayay, R. Karthika Devi, et al.
Neurochemical Research (2025) Vol. 50, Iss. 1
Closed Access | Times Cited: 1

Integrative pharmacological mechanism of vitamin C combined with glycyrrhizic acid against COVID-19: findings of bioinformatics analyses
Rong Li, Ka Wu, Li Yu, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 2, pp. 1161-1174
Open Access | Times Cited: 58

Role of Inflammation in Traumatic Brain Injury–Associated Risk for Neuropsychiatric Disorders: State of the Evidence and Where Do We Go From Here
Victoria B. Risbrough, Melonie N. Vaughn, Samantha F. Friend
Biological Psychiatry (2021) Vol. 91, Iss. 5, pp. 438-448
Closed Access | Times Cited: 42

Perspectives on nano-nutraceuticals to manage pre and post COVID-19 infections
Ankit Kumar Dubey, Suman Kumar Chaudhry, Harikesh Bahadur Singh, et al.
Biotechnology Reports (2022) Vol. 33, pp. e00712-e00712
Open Access | Times Cited: 29

HMGB1 in nervous system diseases: A common biomarker and potential therapeutic target
Di Mao, Zheng Yuan, Fenfen Xu, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 28

HMGB1 mediates cognitive impairment caused by the NLRP3 inflammasome in the late stage of traumatic brain injury
Siwei Tan, Yan Zhao, Ping Li, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 40

Recent Advances in Glycyrrhiza glabra (Licorice)-Containing Herbs Alleviating Radiotherapy- and Chemotherapy-Induced Adverse Reactions in Cancer Treatment
Kai-Lee Wang, Yingchun Yu, Hsin-Yuan Chen, et al.
Metabolites (2022) Vol. 12, Iss. 6, pp. 535-535
Open Access | Times Cited: 26

Glycyrrhizic acid treatment ameliorates anxiety-like behaviour via GLT1 and Per1/2-dependent pathways
Shanbo Ma, Chong Ye, Rui Zhang, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 118013-118013
Closed Access | Times Cited: 5

HMGB1 in depression: An overview of microglial HMBG1 in the pathogenesis of depression
Xiao Huang, Bo Wang, Jing Yang, et al.
Brain Behavior & Immunity - Health (2023) Vol. 30, pp. 100641-100641
Open Access | Times Cited: 12

Cool the Inflamed Brain: A Novel Anti-inflammatory Strategy for the Treatment of Major Depressive Disorder
Wenjun Su, Ting Hu, Chun‐Lei Jiang
Current Neuropharmacology (2023) Vol. 22, Iss. 5, pp. 810-842
Closed Access | Times Cited: 12

HMGB1 Signaling-Mediated Tumor Immunity in Cancer Progress
Jinlin Wen, Xinyan Zhang
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 10
Open Access | Times Cited: 11

Neuroinflammation—A Crucial Factor in the Pathophysiology of Depression—A Comprehensive Review
Andreea Sălcudean, Cristina-Raluca Bodo, Ramona Amina Popovici, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 502-502
Open Access

Glycyrrhizic acid exhibits strong anticancer activity in colorectal cancer cells via SIRT3 inhibition
Zhenkui Zuo, Lulu He, Xiaoyu Duan, et al.
Bioengineered (2021) Vol. 13, Iss. 2, pp. 2720-2731
Open Access | Times Cited: 26

Page 1 - Next Page

Scroll to top